Loading...
XNAS
ATYR
Market cap37mUSD
Jul 09, Last price  
0.58USD
1D
-9.55%
1Q
-30.12%
Jan 2017
-98.07%
IPO
-99.78%
Name

aTyr Pharma Inc

Chart & Performance

D1W1MN
XNAS:ATYR chart
P/E
0.52
P/S
0.09
EPS
1.13
Div Yield, %
—
Shrs. gr., 5y
46.85%
Rev. gr., 5y
105.97%
Revenues
388m
+164,839.57%
000000422,00010,455,000010,386,000353,000235,000387,608,000
Net income
71m
P
-20,014,000-24,350,000-47,973,000-57,855,000-48,207,000-34,515,000-22,237,000-14,958,000-32,464,000-44,277,000-50,389,000-64,023,00071,151,000
CFO
36m
P
-11,378,000-17,311,000-22,824,000-36,797,000-52,861,000-42,364,000-31,063,000-20,013,000-15,301,000-33,075,000-41,886,000-33,220,999-69,119,00036,225,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Ethos Technologies Inc. functions as a third-party administrator for insurance policies in various global markets, including the United States, India, and Singapore. The company offers "Ethos," a comprehensive technology platform designed to transform the process of purchasing, distributing, and overseeing risk for life insurance products among consumers, agents, and insurance providers. Their product portfolio features term, whole, and indexed universal life insurance policies, complemented by offerings such as wills and estate planning assistance, and supplemental health insurance. Ethos serves a broad clientele, encompassing individual consumers, insurance agents, agencies, and carriers. Incorporated in 2016 and based in San Francisco, California, the organization was formerly known as Ethos Insurance Corporation until its name change in August 2016.
URL
https://www.atyrpharma.com/
IPO date
May 07, 2015
Employees
65
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT